GWM
JAZZ icon

Geneos Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Geneos Wealth Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.24K Hold
33
– – ﹤0.01% 2115
2025
Q4 		$5.61K Hold
33
– – ﹤0.01% 2111
2025
Q3 		$4.35K Sell
33
-320
-91% -$38.4K ﹤0.01% 2170
2025
Q2 		$37.5K Sell
353
-57
-14% -$6.19K ﹤0.01% 1724
2025
Q1 		$127K Buy
410
+172
+72% +$22.4K ﹤0.01% 1433
2024
Q4 		$29.3K Sell
238
-8
-3% -$943 ﹤0.01% 1549
2024
Q3 		$27.4K Buy
246
+213
+645% +$23.3K ﹤0.01% 1433
2024
Q2 		$3.52K Buy
33
+2
+6% +$220 ﹤0.01% 1787
2024
Q1 		$3.73K Hold
31
– – ﹤0.01% 1774
2023
Q4 		$3.81K Hold
31
– – ﹤0.01% 1791
2023
Q3 		$4.01K Hold
31
– – ﹤0.01% 1805
2023
Q2 		$3.84K Hold
31
– – ﹤0.01% 1806
2023
Q1 		$4.54K Hold
31
– – ﹤0.01% 1756
2022
Q4 		$4.94K Hold
31
– – ﹤0.01% 1706
2022
Q3 		$4K Sell
31
-15
-33% -$2.28K ﹤0.01% 1741
2022
Q2 		$7K Hold
46
– – ﹤0.01% 2086
2022
Q1 		$7K Sell
46
-18
-28% -$2.61K ﹤0.01% 2226
2021
Q4 		$8K Sell
64
-172
-73% -$22.6K ﹤0.01% 2265
2021
Q3 		$30K Sell
236
-12
-5% -$1.81K ﹤0.01% 1724
2021
Q2 		$45K Buy
248
+46
+23% +$7.97K ﹤0.01% 1532
2021
Q1 		$33K Hold
202
– – ﹤0.01% 1830
2020
Q4 		$33K Buy
+202
New +$30.1K ﹤0.01% 1662
2016
Q4 		– Sell
-103
Closed -$12K – 2072
2016
Q3 		$12K Buy
103
+3
+3% +$404 ﹤0.01% 1307
2016
Q2 		$14K Hold
100
– – ﹤0.01% 1228
2016
Q1 		$13K Buy
+100
New +$12.4K ﹤0.01% 1221

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Geneos Wealth Management's JAZZ Position: Q1 2026 in Review

Geneos Wealth Management held its Jazz Pharmaceuticals (JAZZ) position steady in Q1 2026 at 33 shares worth $6.24K. The position accounts for ﹤0.01% of the portfolio, ranked #2115.

Geneos Wealth Management first reported a position in JAZZ in Q1 2016 and has held it in 25 quarters since. The position peaked at $127K in Q1 2025. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Geneos Wealth Management held 33 shares of Jazz Pharmaceuticals worth $6.24K as of Q1 2026.
  • Geneos Wealth Management left its Jazz Pharmaceuticals share count unchanged in Q1 2026.
  • Jazz Pharmaceuticals made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #2115 holding.
  • Geneos Wealth Management first reported a position in Jazz Pharmaceuticals in Q1 2016 and has held it in 25 quarters since.
  • Geneos Wealth Management's Jazz Pharmaceuticals position peaked at $127K in Q1 2025.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.